|
Biohaven Ltd (NYSE: BHVN) |
|
Biohaven Ltd
BHVN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Biohaven Ltd 's sales fell
in the first quarter of 2025 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.43 %
Biohaven Ltd net loss increased from $-180 millions, to $-222 millions in first quarter of 2025,
• More on BHVN's Growth
|
|
Biohaven Ltd realized a net loss in trailing twelve months.
Biohaven Ltd realized cash reduction of $ -0.83 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.
• More on BHVN's Valuation
|
|
|
|
|
Biohaven Ltd realized net loss in trailing twelve months.
Biohaven Ltd realized cash outflow of $ -0.83per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.
Biohaven Ltd Price to Book Ratio is at 5.65 lower than Industry Avg. of 34.08. and higher than S&P 500 Avg. of 0.01
• More on BHVN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com